Literature DB >> 17288391

A novel strategy for the preparation of naturally occurring phosphocitrate and its partially esterified derivatives.

Petri A Turhanen1, Konstantinos D Demadis, Sirpa Peräniemi, Jouko J Vepsäläinen.   

Abstract

A novel method for the synthesis of phosphocitrate (1, PC) starting from triethyl ester of citric acid and MeOPCl2 is described. The method is based on selective stepwise hydrolysis of ester moieties from the intermediate Me-O-P(O)(Cl)(Z) (Z = triethylcitrate), 4a, which also allows one to prepare partially esterified derivatives of PC with good yield and purity without chromatographic purifications.

Entities:  

Year:  2007        PMID: 17288391     DOI: 10.1021/jo061709c

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  9 in total

1.  Calcium deposition in osteoarthritic meniscus and meniscal cell culture.

Authors:  Yubo Sun; David R Mauerhan; Patrick R Honeycutt; Jeffrey S Kneisl; H James Norton; Natalia Zinchenko; Edward N Hanley; Helen E Gruber
Journal:  Arthritis Res Ther       Date:  2010-03-30       Impact factor: 5.156

2.  Disease-modifying effects of phosphocitrate and phosphocitrate-β-ethyl ester on partial meniscectomy-induced osteoarthritis.

Authors:  Yubo Sun; Nikkole Haines; Andrea Roberts; Michael Ruffolo; David R Mauerhan; Kim L Mihalko; Jane Ingram; Michael Cox; Edward N Hanley
Journal:  BMC Musculoskelet Disord       Date:  2015-09-30       Impact factor: 2.362

3.  Expression of phosphocitrate-targeted genes in osteoarthritis menisci.

Authors:  Yubo Sun; David R Mauerhan; Nury M Steuerwald; Jane Ingram; Jeffrey S Kneisl; Edward N Hanley
Journal:  Biomed Res Int       Date:  2014-11-23       Impact factor: 3.411

4.  Biological Effects of Phosphocitrate on Osteoarthritic Articular Chondrocytes.

Authors:  Yubo Sun; Atiya M Franklin; David R Mauerhan; Edward N Hanley
Journal:  Open Rheumatol J       Date:  2017-05-31

Review 5.  Molecular Crystallization Inhibitors for Salt Damage Control in Porous Materials: An Overview.

Authors:  Maria Paola Bracciale; Svetlana Sammut; JoAnn Cassar; Maria Laura Santarelli; Assunta Marrocchi
Journal:  Molecules       Date:  2020-04-18       Impact factor: 4.411

6.  Phosphocitrate is potentially a disease-modifying drug for noncrystal-associated osteoarthritis.

Authors:  Yubo Sun; David R Mauerhan; Atiya M Franklin; James Norton; Edward N Hanley; Helen E Gruber
Journal:  Biomed Res Int       Date:  2013-02-21       Impact factor: 3.411

7.  Biological activities of phosphocitrate: a potential meniscal protective agent.

Authors:  Yubo Sun; Andrea Roberts; David R Mauerhan; Andrew R Sun; H James Norton; Edward N Hanley
Journal:  Biomed Res Int       Date:  2013-07-11       Impact factor: 3.411

8.  Fibroblast-like synoviocytes induce calcium mineral formation and deposition.

Authors:  Yubo Sun; David R Mauerhan; Atiya M Franklin; Natalia Zinchenko; Harry James Norton; Edward N Hanley; Helen E Gruber
Journal:  Arthritis       Date:  2014-05-20

9.  The role of inhibition by phosphocitrate and its analogue in chondrocyte differentiation and subchondral bone advance in Hartley guinea pigs.

Authors:  Yubo Sun; Alex J Kiraly; Michael Cox; David R Mauerhan; Edward N Hanley
Journal:  Exp Ther Med       Date:  2018-02-07       Impact factor: 2.447

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.